TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II Trial.

Ezra E W Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.